InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.72
(
0.15%
)
US TECH 100
17,667.60
(
0.15%
)
Dow Jones
39,498.98
(
0.28%
)
Brent Oil
82.67
(
-1.53%
)
Bitcoin
60,681.66
(
-3.75%
)
Post# of 251786
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: None

Wednesday, 01/18/2017 9:24:03 AM

Wednesday, January 18, 2017 9:24:03 AM

Post# of 251786
LLY to Acquire CoLucid Pharmaceuticals (CLCD) for $960M
http://www.streetinsider.com/dr/news.php?id=12433510&gfv=1

Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (Nasdaq: CLCD) today announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million. This all-cash transaction will enhance Lilly’s existing portfolio in pain management for migraine, while adding a potential near-term launch to its late-stage pipeline.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up